Page last updated: 2024-09-04

vatalanib and Hypopharyngeal Neoplasms

vatalanib has been researched along with Hypopharyngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baumann, M; Dörfler, A; Eicheler, W; Geyer, P; Haberey, M; Hessel, F; Thames, HD; Zips, D	1

Other Studies

1 other study(ies) available for vatalanib and Hypopharyngeal Neoplasms

Article	Year
Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition. Cancer research, 2005, Jun-15, Volume: 65, Issue:12 Topics: Animals; Blood Vessels; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypopharyngeal Neoplasms; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Phthalazines; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2005

Article

Year

Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.

Cancer research, 2005, Jun-15, Volume: 65, Issue:12

Topics: Animals; Blood Vessels; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypopharyngeal Neoplasms; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Phthalazines; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2005